Prime Medicine PRME
NASDAQ PRME
$3.70 -0.01 (-0.27%)
As of: Sep 4, 2026 · 3:59 PM EDT

Prime Medicine (PRME) Other Operating Expenses (2023)

Prime Medicine's (PRME) quarterly Other Operating Expenses came in at $13.5 million in Q4 2023.

Analysis

Prime Medicine (PRME) Other Operating Expenses (2023) Analysis & Trends

Prime Medicine (PRME) has 1 years of Other Operating Expenses data on file, last reported at $13.5 million in Q4 2023.

  • Quarterly Other Operating Expenses changed N/A year-over-year to $13.5 million in Q4 2023, while the trailing twelve-month figure through Sep 2024 was $13.5 million (changed N/A YoY) and the FY2023 annual result came in at $13.5 million, changed N/A from the prior year.
  • Other Operating Expenses was little changed at $13.5 million in Q4 2023.
  • In the past five years, Other Operating Expenses ranged from a high of $13.5 million in Q4 2023 to a low of $13.5 million in Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Prime Medicine 653.96 Mn 653.96 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 13.50 Mn